trial · primary record
Liver-expressed antimicrobial peptide 2
Obesity & Overweight
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2027-08-01 |
| Primary endpoint | Food intake |
| Registry ID | NCT07897383 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:37.632Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897383
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.